Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The locus of crossover in P1 (loxP) is a 34-base pair DNA sequence derived from the P1 bacteriophage that serves as the specific recognition site for the Cre recombinase enzyme (Sauer, B., 1998, Methods in Enzymology). It consists of two 13-bp palindromic inverted repeats flanking an 8-bp asymmetric spacer region that determines the directionality of the site (Nagy, A., 2000, Genesis). When two loxP sites are introduced into a genome, the Cre-loxP system allows for precise genomic manipulation; depending on the orientation and location of the sites, Cre can catalyze the excision, inversion, or translocation of the intervening DNA (Hardy, S. et al., 1997, Journal of Virology). While not a traditional therapeutic target for small molecules, loxP sites are essential components of conditional gene knockout technologies used to model human diseases and are increasingly utilized in experimental gene therapies. These therapies leverage the system to achieve spatial or temporal control over transgene expression, such as the targeted removal of viral DNA or the activation of therapeutic genes in specific tissues (Kim, H. et al., 2018, Nature Communications; Buchholz, F. et al., 2015, Trends in Biotechnology).
Cre recombinase binds to the 13-bp inverted repeats of two loxP sites, forming a synaptic complex where it facilitates a reciprocal strand exchange through a covalent protein-DNA intermediate, leading to site-specific recombination (Van Duyne, G. D., 2015, Microbiology Spectrum).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Locus of crossover in P1 (loxP) DNA site (loxP).